HEMOGLOBIN, cilt.35, sa.1, ss.47-55, 2011 (SCI-Expanded)
Our aim was to evaluate the prenatal diagnosis of beta-thalassemia (beta-thal) and other hemoglobinopathies in a region with high frequency. After detection by premarital or antenatal screening, 312 patients underwent 420 prenatal diagnostic procedures for 407 fetuses in a 10-year period. Fetal samples were collected by chorionic villi sampling (CVS) in the first trimester and amniocentesis and cordocentesis in the second trimester. Mutation analyses of beta-globin and cytogenetic analyses were performed and the most common mutations detected were: IVS-I-110 (G > A), IVS-II-1 (G > A), IVS-I-6 (T > C) and IVS-II-745 (C > G). Hb S [beta 6(A3)Glu -> Val, GAG > GTG)] was the most common hemoglobin (Hb) variant with a frequency of 6.3%. Among 407 fetuses, 105 (25.8%) were diagnosed as affected, while 201 (49.4%) were carriers and 101 (24.8%) were normal. Cytogenetic analyses revealed nine fetuses (2.3%) with numerical chromosomal abnormalities as regular or mosaicism. Prenatal diagnosis of common hemoglobinopathies is safe and effective. Performing cytogenetic analysis in excess fetal material is an acceptable option.